In this issue of Clinics in Chest Medicine, guest editors Drs. Shannon Kasperbauer and Rachel Thomson bring their considerable expertise to the topic of Nontuberculous Mycobacterial Pulmonary Disease. Nontuberculous mycobacterial pulmonary disease (NTM-PD) is a challenging infection which is becoming increasingly prevalent, particularly in the elderly, for reasons which are unknown. In this issue, top experts discuss topics such as environmental sources and transmission of nontuberculous mycobacteria; global epidemiology; host susceptibility; investigation and management of bronchiectasis in nontuberculous mycobacterial pulmonary disease; and more. - Contains 15 practice-oriented topics including novel antimicrobial agents in nontuberculous pulmonary disease; host directed therapy in nontuberculous pulmonary disease; cystic fibrosis related nontuberculous mycobacterial pulmonary disease; surgical resection in nontuberculous mycobacterial pulmonary disease; and more. - Provides in-depth clinical reviews on nontuberculous mycobacterial pulmonary disease, offering actionable insights for clinical practice. - Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

In this issue of Clinics in Chest Medicine, guest editors Drs. Shannon Kasperbauer and Rachel Thomson bring their considerable expertise to the topic of Nontuberculous Mycobacterial Pulmonary Disease. Nontuberculous mycobacterial pulmonary disease (NTM-PD) is a challenging infection which is becoming increasingly prevalent, particularly in the elderly, for reasons which are unknown. In this issue, top experts discuss topics such as environmental sources and transmission of nontuberculous mycobacteria; global epidemiology; host susceptibility; investigation and management of bronchiectasis in nontuberculous mycobacterial pulmonary disease; and more. Contains 15 practice-oriented topics including novel antimicrobial agents in nontuberculous pulmonary disease; host directed therapy in nontuberculous pulmonary disease; cystic fibrosis related nontuberculous mycobacterial pulmonary disease; surgical resection in nontuberculous mycobacterial pulmonary disease; and more. Provides in-depth clinical reviews on nontuberculous mycobacterial pulmonary disease, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

This book is a comprehensive and authoritative source on nontuberculous mycobacterial (NTM) pathogens and diseases and their appropriate management, with a focus on lung disease. NTM diseases, especially lung diseases, are increasing in prevalence in the U.S. and internationally with concomitant growing interest in a broad section of the medical community. Often merely included in coverage of tuberculosis, many aspects of NTM organisms and diseases are actually very different than TB. These differences are not intuitive or trivial and frequently result in suboptimal management of NTM patients. This book addresses these gaps in the literature with chapters on microbiology, pathophysiology, epidemiology, the various diseases that can stem from NTM, and their particular management. There is also coverage on prevention and NTM as a public health problem. For pulmonologists and infectious disease physicians, this is the definitive resource on nontuberculous mycobacteria.

In this issue, guest editors bring their considerable expertise to this important topic. Provides in-depth reviews on the latest updates in the field, providing actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.

Chronic Obstructive Pulmonary Disease Exacerbations covers the definition, diagnosis, epidemiology, mechanisms, and treatment associated with COPD exacerbations. This text also addresses imaging and how it plays a pivotal role in the diagnosis and study of exacerbations.Written by today's top experts, Chronic Obstructive Pulmonary Disease Exacerbat

Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimicrobial resistance pose particular challenges in combating these diseases. Major Infectious Diseases identifies feasible, cost-effective packages of interventions and strategies across delivery platforms to prevent and treat HIV/AIDS, other sexually transmitted infections, tuberculosis, malaria, adult febrile illness, viral hepatitis, and neglected tropical diseases. The volume emphasizes the need to effectively address emerging antimicrobial resistance, strengthen health systems, and increase access to care. The attainable goals are to reduce incidence, develop innovative approaches, and optimize existing tools in resource-constrained settings.

This report considers the biological and behavioral mechanisms that may underlie the pathogenicity of tobacco smoke. Many Surgeon General's reports have considered research findings on mechanisms in assessing the biological plausibility of associations observed in epidemiologic studies. Mechanisms of disease are important because they may provide plausibility, which is one of the guideline criteria for assessing evidence on causation. This report specifically reviews the evidence on the potential mechanisms by which smoking causes diseases and considers whether a mechanism is likely to be operative in the production of human disease by tobacco smoke. This evidence is relevant to understanding how smoking causes disease, to identifying those who may be particularly susceptible, and to assessing the potential risks of tobacco products.

This open access book focuses on diagnostic and interventional imaging of the chest, breast, heart, and vessels. It consists of a remarkable collection of contributions authored by internationally respected experts, featuring the most recent diagnostic developments and technological advances with a highly didactical approach. The chapters are disease-oriented and cover all the relevant imaging modalities, including standard radiography, CT, nuclear medicine with PET, ultrasound and magnetic resonance imaging, as well as imaging-guided interventions. As such, it presents a comprehensive review of current knowledge on imaging of the heart and chest, as well as thoracic interventions and a selection of "hot topics". The book is intended for radiologists, however, it is also of interest to clinicians in oncology, cardiology, and pulmonology.

This issue of Chest Medicine Clinics focuses on Interventional Pulmonology, with topics including: Flexible bronchoscopy; Radiology for mediastinal lymph node station in lung cancer diagnosis and staging; Lung cancer screening; Early lung cancer detection; Palliative care and interventional pulmonology; Anesthesia for flexible and rigid bronchoscopy; Mediastinal and pulmonary pathology: Specimen collection and processing; Bronchial Thermoplasty: A nonpharmacological therapy for severe asthma; Bronchoscopic lung volume reduction; Malignant pleural effusion: From diagnostics to therapeutics; Intrapleural therapeutics; Percutaneous dilational tracheostomy; Tracheobronchial stenosis and Tracheobroncho malacia: diagnostic and therapeutic dilemmas; Pediatric interventional pulmonology; The Business of Bronchoscopy: How to set up an Interventional Pulmonology Program; Bronchoscopic therapies for peripheral lung malignancies; and Bronchial Thermoplasty: A nonpharmacological therapy for severe asthma.